✦ LIBER ✦

The Role of Induction Therapy for Resectable Non-Small Cell Lung Cancer

✍ Scribed by Dr Thomas E. Stinchcombe, Mark A. Socinski

Book ID: 119928710
Publisher: Springer International Publishing AG
Year: 2007
Tongue: English
Weight: 117 KB
Volume: 67
Category: Article
ISSN: 0012-6667
DOI: 10.2165/00003495-200767030-00001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction treatment for resectable non-s

Induction treatment for resectable non-small-cell lung cancer

✍ Perry, M.C.; Deslauriers, J.; Albain, K.S.; Choi, N.C.; Depierre, A.; Johnston, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Resection of stage III non-small cell lu

Resection of stage III non-small cell lung cancer following induction therapy

✍ Valerie W. Rusch 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 779 KB

Approximately 25%-30% of all patients with non-small cell lung cancer (NSCLC) present with stage III tumors. Except for specific subsets, these tumors are not usually amenable to complete surgical resection and are associated with a 5-year survival of 10% or less. Because patients with stage III NSC

Resection of stage III non-small cell lu

Resection of stage III non-small cell lung cancer following induction therapy

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Intensity of neoadjuvant therapy in rese

Intensity of neoadjuvant therapy in resectable non-small cell lung cancer

✍ Green, Mark R.; Barkley, John E. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 652 KB

Adjuvant Therapy of Resected Non–Small-C

Adjuvant Therapy of Resected Non–Small-Cell Lung Cancer

✍ Mark A. Socinski 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 208 KB

Induction therapy (IT) downstages the me

Induction therapy (IT) downstages the metastatic phenotype of resectable T4 non-small cell lung cancer (NSCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 161 KB